CEACAM5 and prostate carcinoma: Chen et al. reported a SERS-based VFA where one test zone supported the detection of three analytes: Alpha-fetoprotein (AFP), Carcinoembryonic Antigen (CEA), and prostate-specific antigen (PSA), for prostate cancer [36].